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rObjectives: Helium produces preconditioning by activat-
ng prosurvival kinases, but the roles of reactive oxygen
pecies (ROS) or mitochondrial adenosine triphosphate–
egulated potassium (KATP) channels in this process are un-
nown. The authors tested the hypothesis that ROS and
itochondrial KATP channels mediate helium-induced pre-
onditioning in vivo.
Design: A randomized, prospective study.
Setting: A university research laboratory.
Participants: Male New Zealand white rabbits.
Interventions: Rabbits (n  64) were instrumented for the
easurement of systemic hemodynamics and subjected to
 30-minute left anterior descending coronary artery (LAD)
cclusion and 3 hours of reperfusion. In separate experimen-
al groups, rabbits (n  7 or 8 per group) were randomly
ssigned to receive 0.9% saline (control) or 3 cycles of 70%
elium–30% oxygen administered for 5 minutes inter-
persed with 5 minutes of an air-oxygen mixture before LAD
cclusion with or without the ROS scavengers N-acetylcys-
eine (NAC; 150 mg/kg) or N-2 mercaptoproprionyl glycineb
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54 Journal of Cardiothorac-hydroxydecanoate (5-HD; 5 mg/kg). Statistical analysis of
ata was performed with analysis of variance for repeated
easures followed by Bonferroni’s modification of a Stu-
ent t test.
Measurements and Main Results: The myocardial infarct
ize was determined by using triphenyltetrazolium chloride
taining and presented as a percentage of the left ventricular
rea at risk. Helium significantly (p < 0.05) reduced infarct
ize (23  4% of the area at risk; mean  standard deviation)
ompared with control (46  3%). NAC, 2-MPG, and 5-HD did
ot affect irreversible ischemic injury when administered
lone (49  5%, 45  6%, and 45  3%), but these drugs
locked reductions in infarct size produced by helium (45 
%, 45  2%, and 44  3%).
Conclusions: The results suggest that ROS and mitochon-
rial KATP channels mediate helium-induced preconditioning
n vivo.
 2008 Elsevier Inc. All rights reserved.
EY WORDS: myocardial ischemia, preconditioning, helium,
eactive oxygen species, mitochondrial adenosine triphos-2-MPG; 75 mg/kg), or the mitochondrial KATP antagonist phate–regulated potassium channelserican
eEPERFUSION AFTER coronary artery occlusion pro-
duces large quantities of reactive oxygen species (ROS)
hat contribute substantially to myocardial injury.1,2 In con-
rast, small amounts of ROS released from mitochondria
uring a brief episode of ischemia before prolonged coro-
ary occlusion and reperfusion cause preconditioning.3,4
retreatment with free radical scavengers abolished cardio-
rotection produced by ischemic preconditioning.5 Volatile
nesthetics also directly produce small quantities of ROS6,7
most likely from mitochondrial electron transport chain
omplex III8) through activation of mitochondrial adenosine
riphosphate–regulated potassium (KATP) channels.9,10 As
bserved during ischemic preconditioning, ROS generated
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1053-0770/08/2204-0008$34.00/0y this form of pharmacologic preconditioning mediated
eductions in myocardial infarct size produced by the volatile
gent.6,7,10 Brief, intermittent administration of helium before
rolonged coronary artery occlusion and reperfusion was re-
ently shown to protect myocardium against infarction by
ctivating prosurvival signaling kinases (eg, phosphotidylinosi-
ol-3-kinase, extracellular signal-regulated kinases, and endo-
helial nitric oxide synthase), attenuating the detrimental
ctions of glycogen synthase kinase, and inhibiting mito-
hondrial transition in vivo.11-13 Whether oxygen-derived
ree radical intermediates play a role in helium-induced
reconditioning is unknown. Brief exposure to the anesthetic
oble gas xenon produced cardioprotection by activating
itochondrial KATP channels,14 but the role of mitochondrial
ATP channels in cardioprotection by nonanesthetic noble
ases remains undefined. Thus, the current investigation also
ested the hypothesis that the activation of mitochondrial
ATP channels mediates helium-induced preconditioning in
abbits.
METHODS
All experimental procedures and protocols used in this investigation
ere reviewed and approved by the Animal Care and Use Committee
f the Medical College of Wisconsin. Furthermore, all conformed to
he Guiding Principles in the Care and Use of Animals of the Am
hysiologic Society and were in accordance with the Guide for th
are and Use of Laboratory Animals.
Male New Zealand white rabbits weighing between 2.5 and 3.0 kg
ere anesthetized with intravenous sodium pentobarbital (30 mg/kg) as
reviously described.11 Additional doses of pentobarbital were titrated
s required to ensure that pedal and palpebral reflexes were absent
hroughout the experiment. Briefly, a tracheostomy was performed
hrough a midline incision, and each rabbit was ventilated with positive
ic and Vascular Anesthesia, Vol 22, No 4 (August), 2008: pp 554-559
p
c
w
r
o
m
c
v
a
k
c
w
a
l
t
a
d
b
i
d
o
n
r
u
f
r
t
m
b
s
p
c
2
i
0
o
i
s
o
t
p
T
a
c
B
a
v
i
555HELIUM, ROS, AND MITOCHONDRIAL KATP CHANNELSressure using an air-oxygen mixture (fractional inspired oxygen con-
entration  0.30). Arterial blood gas tensions and acid-base status
ere maintained within a normal physiologic range by adjusting the
espiratory rate or tidal volume throughout the experiment. A pulse
ximeter was placed on the right hind paw of each rabbit for the
easurement of continuous arterial oxygen saturation. Heparin-filled
atheters were positioned in the right carotid artery and the left jugular
ein for measurement of arterial blood pressure and fluid or drug
dministration, respectively. Maintenance fluids (0.9% saline; 15 mL/
g/.min) were continued for the duration of each experiment. A thora-
otomy was performed at the left fourth intercostal space, and the heart
as suspended in a pericardial cradle. A prominent branch of the left
nterior descending coronary artery (LAD) was identified, and a silk
igature was placed around this vessel approximately halfway between
he base and the apex for the production of coronary artery occlusion
nd reperfusion. Intravenous heparin (500 U) was administered imme-
iately before LAD occlusion. Coronary artery occlusion was verified
y the presence of epicardial cyanosis and regional dyskinesia in the
schemic zone, and reperfusion was confirmed by observing an epicar-
ial hyperemic response. Hemodynamics were continuously recorded
n a polygraph throughout each experiment.
The experimental design is shown in Figure 1. Baseline hemody-
amics, arterial blood gas tensions, and arterial oxygen saturation were
ecorded 30 minutes after instrumentation was completed. All rabbits
nderwent a 30-minute LAD occlusion followed by 3 hours of reper-Fig 1. Schematic illustration depicting the experimusion. In 8 separate groups, rabbits (n  7 to 8 per group) were
andomly assigned (Latin square design) to receive 0.9% saline (con-
rol) or 3 cycles of 70% helium–30% oxygen administered for 5
inutes interspersed with 5 minutes of 70% nitrogen–30% oxygen
efore coronary artery occlusion in the presence or absence of the ROS
cavengers N-acetylcysteine (NAC, 150 mg/kg) or N-2 mercaptopro-
rionyl glycine (2-MPG, 75 mg/kg) or the selective mitochondrial KATP
hannel antagonist 5-hydroxydeconate (5-HD, 5 mg/kg). NAC and
-MPG were dissolved in 0.9% saline and administered as intravenous
nfusions over 30 and 75 minutes, respectively. 5-HD was dissolved in
.9% saline and administered intravenously 30 minutes before LAD
cclusion. The doses of NAC, 2-MPG, and 5-HD used in the current
nvestigation did not produce hemodynamic effects nor affect infarct
ize when administered alone in an identical rabbit model.7,10 The doses
f NAC, 2-MPG, and 5-HD also abolished isoflurane-induced produc-
ion of ROS as detected by dihydroethidium staining independent of
rolonged coronary artery occlusion and reperfusion in rabbits.7,10
aken together, these previous findings suggest that these particular
ntagonists are effective and selective in the doses that were used in the
urrent investigation.
Myocardial infarct size was measured as previously described.15
riefly, the LAD was reoccluded at the completion of each experiment,
nd 3 mL of patent blue dye were injected intravenously. The left
entricular area at risk for infarction was separated from the surround-
ng normal areas (stained blue), and the 2 regions were incubated atental protocol used in the current investigation.
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556 PAGEL ET AL7°C for 20 minutes in 1% 2,3,5 triphenyltetrazolium chloride in 0.1
ol/L of phosphate buffer adjusted to pH 7.4. Infarcted and nonin-
arcted myocardium within the area at risk were carefully separated and
eighed after storage overnight in 10% formaldehyde. Myocardial
nfarct size was expressed as a percentage of the area at risk. Rabbits
hat developed intractable ventricular fibrillation and those with an area at
isk less than 15% of the total left ventricular mass were excluded from
ubsequent analysis.
Statistical analysis of data within and between groups was performed
ith multiple analysis of variance for repeated measures followed by
onferroni’s modification of a Student t test.16 Changes were consid-
red statistically significant when p  0.05. All data are expressed as
ean  standard deviation.
RESULTS
Sixty-four rabbits were instrumented to obtain 59 successful
nfarct size experiments. Two rabbits were excluded because
he left ventricular area at risk was less than 15% of the total
eft ventricular mass. Three rabbits were excluded because
ntractable ventricular fibrillation occurred during coronary ar-
ery occlusion. Arterial blood gas tensions were maintained
ithin the physiologic range during the administration of he-
ium in all groups (data not shown). Arterial oxygen saturation
Table 1. H
Baseline Intervention
HR (beats/min)
CON 236  23 226  21
He 255  29 238  28
5-HD 243  28 236  22
5-HD  He 229  24 219  22
NAC 253  28 253  22
NAC  He 246  28 234  24
2-MPG 236  24 254  26
2-MPG  He 226  23 221  20
MAP (mmHg)
CON 71  9 65  9
He 75  8 80  17
5-HD 69  2 74  10
5-HD  He 71  7 71  9
NAC 85  9 86  6†
NAC  He 75  8 74  6
2-MPG 89  8† 84  6†
2-MPG  He 72  4 71  5
RPP (min/mmHg/103)
CON 18.9  2.4 17.0  2.9
He 21.6  3.7 21.6  6.1
5-HD 19.4  2.3 19.6  2.7
5-HD  He 18.5  2.7 17.7  3.1
NAC 24.5  4.5 24.4  3.0†
NAC  He 21.0  3.5 19.7  3.2
2-MPG 23.6  2.9 24.5  3.5†
2-MPG  He 18.5  2.0 17.9  2.5
NOTE. Data are mean  standard deviation.
Abbreviations: HR, heart rate; MAP, mean arterial pressure; RPP, ra
*Significantly (p  0.05) different from baseline.
†Significantly (p  0.05) different from the corresponding control.emained at 100% during and after the administration of helium dith or without other drug interventions (data not shown).
aseline systemic hemodynamics were similar between groups
Table 1), but the mean arterial pressure was greater in rabbits
andomized to receive 2-MPG compared with 0.9% saline.
elium did not affect hemodynamics. The mean arterial pres-
ure and rate-pressure product were greater in rabbits receiving
AC or 2-MPG alone before LAD occlusion compared with
hose treated with 0.9% saline. Brief coronary artery occlusion
nd reperfusion significantly (p  0.05) reduced rate-pressure
roduct in all experimental groups. There were no differences
n hemodynamics between groups during LAD occlusion and
eperfusion. Body weight, left ventricular mass, area at risk
eight, and the ratio of area at risk to left ventricular mass were
imilar between groups (Table 2). Left ventricular weight and
rea at risk weight were less in rabbits randomized to receive
AC compared with 0.9% saline, but the ratio of area at risk to
he left ventricular mass was similar between these groups.
rief, intermittent exposure to 70% helium before LAD occlu-
ion reduced myocardial infarct size (23  4% of the left
entricular area at risk) as compared with control rabbits (46 
%, Fig 2). The administration of NAC, 2-MPG, or 5-HD alone
ynamics
lusion
Reperfusion (min)
60 120 180
 27 216  16* 211  21* 203  20*
 14* 220  29* 209  25* 200  27*
 27 221  29 208  26* 203  27*
 19* 196  16* 189  10* 184  9*
 31 238  33 235  37 232  39
 18 214  22* 207  23* 196  29*
 35 236  11 229  25 237  34
 25 205  23 192  19* 186  18*
 10 62  10 63  11 62  11
 7 66  10 68  6 67  16
 11 60  12 55  10 54  9
 11 65  10 64  10 66  7
 11 71  11* 72  12* 73  13*
 13 61  8* 62  10* 61  6*
 16* 68  15* 73  21 75  19
 12* 63  10 63  10 65  9
 1.8 15.6  2.6* 15.5  3.2* 14.7  3.4*
 2.3 16.8  3.3* 16.4  2.4* 15.3  4.1*
 1.6 15.5  3.2* 13.3  3.1* 13.2  2.7*
 3.2* 14.8  3.0* 14.1  2.3* 14.1  1.8*
 4.1 19.4  4.9* 19.7  5.6* 19.8  6.1
 3.3* 15.1  2.0* 14.9  2.3* 13.8  2.0*
 4.2 18.3  3.5* 19.1  5.2* 20.1  4.9
 4.0* 15.0  2.8* 14.0  2.5* 14.0  2.5*
essure product; CON, control; He, helium.emod
Occ
230
228
225
206
244
223
261
206
61
69
61
61
76
60
68
55
16.1
17.9
15.6
14.7
21.2
15.3
20.2
13.6
te-prid not affect infarct size (49  5%, 45  6%, and 45  3%,
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557HELIUM, ROS, AND MITOCHONDRIAL KATP CHANNELSespectively), but these drugs abolished helium-induced cardio-
rotection (45  4%, 44  2%, and 44  3%, respectively).
DISCUSSION
The current results confirm the previous findings,11-13 indi-
ating that 3 cycles of 5 minutes of 70% helium–30% oxygen
reconditioning interspersed with 5-minute washout periods of
n air-oxygen mixture reduce myocardial necrosis after pro-
onged coronary artery occlusion and reperfusion. The results
how for the first time that pretreatment with NAC or 2-MPG
bolishes this helium-induced cardioprotection, suggesting that
OS mediate preconditioning by the nonanesthetic noble gas in
ivo. The results further indicate that 5-HD pretreatment blocks
eductions in myocardial infarct size produced by brief, inter-
ittent administration of helium, implicating mitochondrial
ATP channels in this process as well. Weber et al14 showed that
itochondrial KATP channels mediated cardioprotection pro-
uced by the anesthetic inert gas xenon,14 and the current
esults extend this observation to another noble gas that is
evoid of anesthetic properties, even under extreme hyperbaric
onditions (200 atm).17 Collectively, the current and previ-
Table 2. Left Ve
N Body Weight (g)
CON 8 2,703  298
He 8 2,803  243
5-HD 7 2,789  231
5-HD  He 7 2,487  72
NAC 8 2,709  280
NAC  He 7 2,594  82
2-MPG 7 2,847  170
2-MPG  He 7 2,726  112
NOTE. Data are mean  standard deviation.
Abbreviations: LV, left ventricle; AAR, area at risk; CON, control; H
*Significantly (p  0.05) different from the corresponding CON val
Fig 2. Myocardial infarct size depicted as a percentage of left ventr
f 70% helium–30% oxygen administered for 5 minutes interspersed
bsence of pretreatment with the ROS scavengers NAC (150 mg/kg) o
-HD (5 mg/kg) before prolonged coronary artery occlusion and reperfusi
tandard deviation. *Significantly (p < 0.05) different from CON.us14 data with noble gases also lend support to the hypothesis
hat ROS are a ubiquitous feature in preconditioning phenom-
na in conjunction with mitochondrial KATP channels. Pretreat-
ent with low concentrations of ROS mimicked the beneficial
ffects of ischemic preconditioning,18 and small quantities of
OS generated by mitochondria during brief periods of isch-
mia3,4 or after exposure to the mitochondrial KATP channel
gonist diazoxide19,20 have been shown to play a central role in
schemic and pharmacologic preconditioning, respectively. Ev-
dence that mitochondrial KATP activation mediates this ROS-
nduced cardioprotection also was provided by the observations
hat diazoxide enhances oxidation of the ROS probe Mito-
racker orange20 (Molecular Probes, Eugene, OR) and increases
OS production as measured using 2=,7=-dichlorofluorescein
iacetate in rat ventricular myocytes or isolated hearts.21 Pre-
reatment with 5-HD abolished ROS generation produced by
he mitochondrial KATP channel openers nicorandil and cro-
akalim in isolated rat hearts.22 Similarly, the ROS scavengers
AC, 2-MPG, and Mn(III)tetrakis (4-benzoic acid) porphyrin
hloride inhibited the cardioprotective effects of isoflurane in
solated6 and intact rabbit hearts.7,10 Scavengers of ROS also
lar Area at Risk
LV (g) AAR (g) AAR/LV (%)
3.90  0.46 1.63  0.20 42  5
3.84  0.21 1.26  0.08 33  2
3.49  0.39 1.36  0.34 39  6
3.58  0.25 1.34  0.17 37  4
3.08  0.48* 1.02  0.33* 33  6
3.74  0.45 1.35  0.37 36  7
3.32  0.63 1.18  0.48 35  9
3.58  0.44 1.47  0.25 41  4
ium.
area at risk in rabbits receiving 0.9% saline (control, CON) or 3 cycles
5 minutes of an air-oxygen mixture (FIO2  0.30) in the presence or
PG (75 mg/kg) or the selective mitochondrial KATP channel antagonistntricu
e, helicular
with
r 2-Mon. Each point represents a single experiment. All data are mean 
ad
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558 PAGEL ET ALbolished the salutary actions of sevoflurane against ischemic
amage in isolated guinea pig hearts.23,24 Preconditioning by
soflurane directly increased the production of superoxide anion
O2) as determined using dihydroethidium staining through a
itochondrial KATP channel-mediated mechanism.8,10 Thus, it
as become abundantly clear that ROS and mitochondrial KATP
hannels play complementary roles during ischemic, pharma-
ologic, and anesthetic preconditioning, and the current results
ith helium suggest that ROS and mitochondrial KATP channels
re also essential in preconditioning by the nonanesthetic noble
as.
The current results must be interpreted within the constraints
f several potential limitations. Based on previous experiments
onducted with volatile anesthetics,7,8,10 it appears highly likely
hat O2 generated from the electron transport chain though
itochondrial KATP channel opening may also be responsible
or the observed results with helium. The sulfhydryl-containing
lutathione precursor NAC produces antioxidant effects by
nhancing glutathione synthesis, acting as a substrate for glu-
athione peroxidase, and facilitating metabolism of hydrogen
eroxide (H2O2) by univalent reduction of O2 via preservation
f intracellular-reduced glutathione concentration.25 Large
mounts of superoxide dismutase are contained within mito-
hondria, and this enzyme is primarily responsible for the
hemical conversion of O2 to H2O2 and water. The subsequent
eduction of H2O2 is catalyzed by glutathione peroxidase to
hich reduced glutathione serves as an electron donor during
he reaction. Thus, the current observation that NAC abolishes
elium-induced preconditioning indirectly infers that O2 or
ne of its immediate derivatives is responsible for this cardio-
rotective effect; 2-MPG also donates sulfhydryl groups to
lutathione peroxidase and may be more mitochondria-specific
han NAC.26-28 These observations also indirectly suggest that
2
 derived from mitochondria or another oxygen-derived free
adical intermediate produced by O2 metabolism is involved
n cardioprotection by helium. Nevertheless, such conclusions
ust be qualified because the authors did not specifically
etermine the identity or define the source of the ROS involved
n helium-induced preconditioning in the current investigation.
t is also unclear based on the current results whether mito-
hondrial KATP opening acts as a trigger or end-effector for
reconditioning by helium through ROS generation. The au-
hors’ laboratory is currently examining this hypothesis. i
REN
nd N-2mercaptopropionyl glycine attenuate infarct size limitation
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1In addition to previously described limitations, the current
esults must be interpreted within the constraints of several
ther potential shortcomings. The duration of administration
f NAC, 2-MPG, and 5-HD were heterogenous, and these
harmacokinetic factors may have influenced the results.
lasma concentrations of NAC, 2-MPG, and 5-HD also were
ot determined nor were dose-response relationships to these
rugs performed. Myocardial infarct size is determined pri-
arily by the size of the area at risk and the extent of
oronary collateral perfusion. The area at risk expressed as
percentage of total left ventricular mass was similar be-
ween groups in the current investigation, and coronary
ollateral blood flow has been shown to be minimal in
abbits.29 Thus, differences in collateral perfusion between
roups probably did not account for the observed results, but
oronary collateral blood flow was not specifically quanti-
ed. The reductions in myocardial necrosis produced by
elium in the absence or presence of other drug interventions
ccurred independent of changes in major determinants of
yocardial oxygen consumption. Nevertheless, coronary ve-
ous oxygen tension was not directly measured nor was
yocardial oxygen consumption calculated. Notably, no sig-
ificant differences in hemodynamics were observed be-
ween groups before and during coronary artery occlusion
hat may account for differences in infarct size observed
etween groups. Finally, the current results implicating a
ole for ROS and mitochondrial KATP channels in helium-
nduced cardioprotection were obtained in barbiturate-anes-
hetized, acutely instrumented rabbits. Whether similar re-
ults occur in other animal species or humans is unknown.
elium preconditioning has yet to be established in humans,
ut the administration of this noble gas before a defined
eriod of myocardial ischemia may be beneficial in a clinical
etting in which an anesthetic is not required (eg, inflation of
n angioplasty balloon during cardiac catheterization). How-
ver, additional investigation will be required to test this
ntriguing hypothesis.
In summary, the current results confirm that brief, intermit-
ent administration of helium before prolonged coronary artery
cclusion and reperfusion protects myocardium against infarc-
ion. The findings further suggest that ROS and mitochondrial
ATP channels mediate this helium-induced preconditioning
n vivo.REFE
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